Durect Corp Reports Results For The Quarter Ended September 30: Earnings Summary

DURECT

14/11/2024 04:05

* DURECT Corp  DRRX.OQ  reported a quarterly adjusted loss
of 14
cents​​ per share for the quarter ended September 30, identical
to the same quarter last year.  The mean expectation of
three analysts for the quarter was for a loss of 17 cents per
share. Wall Street expected results to range from -29 cents
to -9 cents per share.
    * Revenue rose 10.5% to $1.93 million from a year ago;
analysts
expected $1.98 million. 
    * DURECT Corp's reported EPS for the quarter was a loss
of 14
cents​.
    * The company reported a quarterly loss of $4.29 million.
    * DURECT Corp shares had fallen by 3.7% this quarter and
gained 118.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 7.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for DURECT Corp is
$6.75 
This summary was machine generated from LSEG data November 14 at
04:05 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -0.17          -0.14          Beat
 Jun. 30 2024      -0.17          -0.12          Beat
 Mar. 31 2024      -0.22          -0.25          Missed
 Dec. 31 2023      -0.33          -0.10          Beat